{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:40:24Z","timestamp":1794876024114,"version":"4.9.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T00:00:00Z","timestamp":1533859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jbspin.2018.07.004","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T13:05:56Z","timestamp":1533301556000},"page":"301-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":409,"title":["Methotrexate mechanism in treatment of rheumatoid arthritis"],"prefix":"10.1016","volume":"86","author":[{"given":"Benjamin","family":"Friedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Cronstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2018.07.004_bib0005","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJM198503283121303","article-title":"Efficacy of low-dose methotrexate in rheumatoid arthritis","volume":"312","author":"Weinblatt","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0010","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/ard.2008.092668","article-title":"Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature","volume":"68","author":"Visser","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.hoc.2012.02.002","article-title":"The antifolates","volume":"26","author":"Visentin","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/rheumatology\/keh088","article-title":"Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review","volume":"43","author":"Whittle","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0025","first-page":"563","article-title":"Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate","volume":"32","author":"Pichlmeier","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0030","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4161\/cbt.22020","article-title":"The human proton-coupled folate transporter: Biology and therapeutic applications to cancer","volume":"13","author":"Desmoulin","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2125.1993.tb04158.x","article-title":"The pharmacokinetics of methotrexate and its 7-hydroxy metabolite in patients with rheumatoid arthritis","volume":"35","author":"Seideman","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0040","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/art.1780330620","article-title":"Biliary elimination of low-dose methotrexate in humans","volume":"33","author":"Nuernberg","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1365-2125.1998.t01-1-00790.x","article-title":"The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis","volume":"46","author":"Godfrey","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0050","first-page":"313","article-title":"Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis","volume":"17","author":"Angelis-Stoforidis","year":"1999","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.jbspin.2018.07.004_bib0055","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2016.175","article-title":"Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers","author":"Brown","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0060","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/S0024-3205(00)00559-2","article-title":"Effects of methotrexate on nucleotide pools in normal human T cells and the CEM T cell line","volume":"66","author":"Budzik","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/bj3420143","article-title":"Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?","volume":"342","author":"Fairbanks","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrrheum.2016.178","article-title":"Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases","volume":"13","author":"Cronstein","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/bj2360193","article-title":"Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5\u2019-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide","volume":"236","author":"Baggott","year":"1986","journal-title":"Biochem J"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0080","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd2638","article-title":"Adenosine receptors: therapeutic aspects for inflammatory and immune diseases","volume":"7","author":"Hasko","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0085","doi-asserted-by":"crossref","first-page":"R197","DOI":"10.1186\/ar3527","article-title":"A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release","volume":"13","author":"Varani","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0090","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1002\/art.24794","article-title":"Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate","volume":"60","author":"Varani","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0095","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.4049\/jimmunol.170.6.3337","article-title":"The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis","volume":"170","author":"Nguyen","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0100","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1073\/pnas.88.6.2441","article-title":"Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells","volume":"88","author":"Cronstein","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0105","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1172\/JCI116884","article-title":"The anti-inflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation","volume":"92","author":"Cronstein","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0110","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar1914","article-title":"Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis","volume":"8","author":"Montesinos","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0115","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.22643","article-title":"The anti-inflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5\u2019-nucleotidase: findings in a study of ecto-5\u2019-nucleotidase gene-deficient mice","volume":"56","author":"Montesinos","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1172\/JCI1554","article-title":"Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5\u2019-nucleotidase-mediated conversion of adenine nucleotides","volume":"101","author":"Morabito","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0125","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood.V90.4.1600","article-title":"Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T cell activation and expansion","volume":"90","author":"Huang","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0130","doi-asserted-by":"crossref","first-page":"25881","DOI":"10.1074\/jbc.272.41.25881","article-title":"Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells","volume":"272","author":"Koshiba","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0135","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1073\/pnas.1516525113","article-title":"Dispersal limitation induces long-term biomass collapse in overhunted Amazonian forests","volume":"113","author":"Peres","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0140","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/978-3-540-89615-9_13","article-title":"Adenosine receptors in wound healing, fibrosis and angiogenesis","volume":"193","author":"Feoktistov","year":"2009","journal-title":"Handb Exp Pharmaco"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0145","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/labinvest.2011.9","article-title":"Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis","volume":"91","author":"Teramachi","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0150","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.bjp.0705054","article-title":"The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species","volume":"138","author":"Phillips","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0155","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/art.30457","article-title":"Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK","volume":"63","author":"Spurlock","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0160","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/rheumatology\/37.5.502","article-title":"Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis","volume":"37","author":"Dolhain","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0165","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2004.09.001","article-title":"The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules","volume":"114","author":"Johnston","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0170","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/03009740701406460","article-title":"Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis","volume":"36","author":"Klimiuk","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0175","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1124\/mol.104.001107","article-title":"Specific inhibition of nuclear factor-kappaB-dependent inflammatory responses by cell type-specific mechanisms upon A2A adenosine receptor gene transfer","volume":"66","author":"Sands","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0180","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/rheumatology\/keg323","article-title":"Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis","volume":"42","author":"Gerards","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0185","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/ard.59.4.311","article-title":"Response to methotrexate in early rheumatoid arthritis is associated with a decrease of T cell derived tumour necrosis factor alpha, increase of interleukin 10, and predicted by the initial concentration of interleukin 4","volume":"59","author":"Rudwaleit","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0190","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4049\/jimmunol.173.2.1463","article-title":"L-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate","volume":"173","author":"Miranda-Carus","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0195","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrrheum.2010.5","article-title":"Methotrexate\u2009\u2013\u2009how does it really work?","volume":"6","author":"Chan","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0200","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/ard.50.9.637","article-title":"In vitro effects of methotrexate on peripheral blood monocytes: modulation by folinic acid and S-adenosylmethionine","volume":"50","author":"Nesher","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0205","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/art.1780290703","article-title":"Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates","volume":"29","author":"Kremer","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0210","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1172\/JCI111512","article-title":"Ethanol-induced activation of adenine nucleotide turnover. Evidence for a role of acetate","volume":"74","author":"Puig","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0215","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjp.0706812","article-title":"Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis","volume":"148","author":"Chan","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0220","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/S0002-9440(10)61151-0","article-title":"Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors","volume":"160","author":"Montesinos","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0225","first-page":"1308","article-title":"Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis","volume":"40","author":"Merrill","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0230","first-page":"CD000951","article-title":"Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis","author":"Shea","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0235","doi-asserted-by":"crossref","first-page":"833","DOI":"10.7326\/0003-4819-121-11-199412010-00002","article-title":"Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial","volume":"121","author":"Morgan","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0240","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2217\/pgs-2016-0125","article-title":"ATIC missense variant affects response to methotrexate treatment in rheumatoid arthritis patients","volume":"17","author":"Kurzawski","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0245","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00296-016-3523-2","article-title":"Association of the ATIC 347 C\/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis","volume":"36","author":"Lee","year":"2016","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0250","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.intimp.2016.05.012","article-title":"The association between reduced folate carrier-1 gene 80G\/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis","volume":"38","author":"Li","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0255","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2217\/pgs-2016-0067","article-title":"Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome","volume":"17","author":"Lima","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0260","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/rheumatology\/ken182","article-title":"Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX","volume":"47","author":"Hider","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0265","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.2011.406","article-title":"Development of anti-drug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up","volume":"305","author":"Bartelds","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0270","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/rheumatology\/ker124","article-title":"Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis","volume":"50","author":"Pascual-Salcedo","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0275","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/ard.2006.065615","article-title":"Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis","volume":"66","author":"Bartelds","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0280","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/ard.2009.112847","article-title":"Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study","volume":"69","author":"Bartelds","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0285","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","article-title":"Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis","volume":"41","author":"Maini","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0290","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1002\/art.22214","article-title":"Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab","volume":"54","author":"Bendtzen","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0295","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/ar3147","article-title":"The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review","volume":"12","author":"Krieckaert","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2018.07.004_bib0300","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/rheumatology\/ket260","article-title":"The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases","volume":"53","author":"Jani","year":"2014","journal-title":"Rheumatology (Oxford)"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18301817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18301817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:24:17Z","timestamp":1761150257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X18301817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1297319X18301817"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2018.07.004","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate mechanism in treatment of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2018.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie.","name":"copyright","label":"Copyright"}]}}